Vir Biotechnology VIR is gearing up to announce its quarterly earnings on Thursday, 2024-10-31. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Vir Biotechnology will report an earnings per share (EPS) of $-1.05.
Vir Biotechnology bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Historical Earnings Performance
During the last quarter, the company reported an EPS missed by $0.13, leading to a 5.34% drop in the share price on the subsequent day.
Here's a look at Vir Biotechnology's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.89 | -1.05 | -1.01 | -1.21 |
| EPS Actual | -1.02 | -0.48 | -0.86 | -1.22 |
| Price Change % | -5.0% | 13.0% | 12.0% | 7.000000000000001% |
To track all earnings releases for Vir Biotechnology visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
